|
Brunswick Laboratories Improves Productivity with the
Centrifan PE
"Now with the revolutionary
new Centrifan PE, we can remove solvents much faster and safer."
Dr. Jianxin Chen, Brunswick Laboratories
About: Brunswick Laboratories is a Massachusetts-based
independent contract laboratory and research organization
providing analytical and R & D services to the nutraceutical,
pharmaceutical, food and cosmetic industries.
Problem: Brunswick Laboratories utilizes
the Yamazen Automated Flash
Chromatography System
(AI-580) with
Luknova and Agela normal phase / reverse phase columns (C18 and
HILIC) in their
chemistry Lab. Multiple fractions
are typically collected after the Flash LC run and solvents must
be removed from the fraction collection tubes prior to advancing
the sample to the next analytical step. They used a conventional
rotary evaporator to accomplish the solvent removal task. The
process was slow as the rotorvap could only process one fraction
at a time and the instrument cumbersome for the task at hand as
it required coolant and a vacuum connection. They were also
concerned with bumping and splashing that sometimes occurred
during the rotorvap process that could destroy valuable samples.
Solution: Brunswick Laboratories turned to the
Centrifan PE Personal Evaporator as a fast, safe way to remove
solvents from multiple fraction collection tubes simultaneously.
The Centrifan PE employs a novel, recirculating evaporation
technique that operates without vacuum and eliminates the
potential for cross contamination and sample loss caused by
solvent bumping or splashing. As a result, Brunswick Laboratory
has improved lab productivity by substituting the rotorvap with the
Centrifan PE. They are able to dry more samples in less time and
no longer risk losing valuable samples caused by
vacuum-based evaporation techniques.
"This unique instrument works
very well. It is smooth and quick, no bumping or splashing, and
can evaporate multiple fraction tubes simultaneously instead of
drying the tubes one at a time on a rotorvap," said Dr. Jianxin
Chen, R & D Director, Brunswick Laboratories. |